Astria Therapeutics, Inc.: cash_and_equivalents

Value{"amount": 45972000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2022-09-30)
Statuscurrent
EntityAstria Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001104659-22-117095 · Open the official SEC filing →
Retrieved: 2026-08-19T14:22:38.938284+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001454789/cash-and-equivalents/2022-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/73332a36-b3fa-4812-9028-bd2ba0a1d2dd

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies